Eagle Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-457,077	Closed	-$78.7M	–	637
2021 Q3	$78.7M	Sell	457,077 -3,176	-0.7%	-$547K	0.36%	108
2021 Q2	$57.8M	Sell	460,253 -153	-0%	-$19.2K	0.25%	142
2021 Q1	$63.5M	Sell	460,406 -277,134	-38%	-$38.3M	0.28%	136
2020 Q4	$94.4M	Sell	737,540 -64,463	-8%	-$8.25M	0.53%	49
2020 Q3	$90.7M	Sell	802,003 -96,897	-11%	-$11M	0.47%	83
2020 Q2	$86.4M	Buy	898,900 +294,046	+49%	+$28.3M	0.49%	74
2020 Q1	$54.4M	Sell	604,854 -309,549	-34%	-$27.8M	0.34%	111
2019 Q4	$48.5M	Sell	914,403 -4,955	-0.5%	-$263K	0.23%	166
2019 Q3	$36.3M	Buy	919,358 +11,028	+1%	+$436K	0.19%	182
2019 Q2	$37.3M	Buy	908,330 +29,753	+3%	+$1.22M	0.19%	189
2019 Q1	$40.9M	Buy	878,577 +988	+0.1%	+$46K	0.22%	178
2018 Q4	$38.2M	Sell	877,589 -4,570	-0.5%	-$199K	0.24%	168
2018 Q3	$50.5M	Sell	882,159 -6,252	-0.7%	-$358K	0.24%	170
2018 Q2	$43.1M	Sell	888,411 -338,285	-28%	-$16.4M	0.23%	165
2018 Q1	$48M	Sell	1,226,696 -3,282	-0.3%	-$128K	0.26%	141
2017 Q4	$52.2M	Sell	1,229,978 -15,073	-1%	-$639K	0.29%	119
2017 Q3	$47.1M	Sell	1,245,051 -11,591	-0.9%	-$438K	0.27%	132
2017 Q2	$38.2M	Buy	1,256,642 +77,683	+7%	+$2.36M	0.23%	155
2017 Q1	$31.2M	Buy	1,178,959 +4,100	+0.3%	+$109K	0.2%	164
2016 Q4	$30M	Buy	1,174,859 +367,884	+46%	+$9.39M	0.2%	157
2016 Q3	$29.2M	Buy	806,975 +83,146	+11%	+$3.01M	0.2%	162
2016 Q2	$24.6M	Sell	723,829 -52,627	-7%	-$1.79M	0.17%	178
2016 Q1	$20.5M	Buy	+776,456	New	+$20.5M	0.14%	209